Global PrEP Tracker
This sortable database includes quarterly updates on national programs delivering oral PrEP, country guidelines and targets, drug registration status and more.
Countries are at varying stages of introducing daily oral tenofovir-based PrEP, which is recommended by WHO as a prevention option for people at substantial risk of HIV. Some countries have national programs; others have smaller-scale programs; others aren’t offering PrEP at all.
In this regularly updated map, yellow countries have some form of PrEP programming; blue countries do not. Want to take the next step in expanding access to PrEP? Check out PrEP Planning A-Z.
This step-by-step framework for scaling up PrEP outlines what's involved for introducing oral PrEP and provides links to tools and resources.
This sortable database includes quarterly updates on national programs delivering oral PrEP, country guidelines and targets, drug registration status and more.
As oral PrEP rolls out globally, implementers are facing and overcoming real-world obstacles. Lessons from the Field brings you these stories. Come here to learn from others, sharpen insights and find useful resources.
An analysis of global PrEP uptake, based on quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and data from manufacturers and government agencies.
A long-acting antiretroviral drug given as an injection every two months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic.